Literature DB >> 26405955

Identification of 13 blood-based gene expression signatures to accurately distinguish tuberculosis from other pulmonary diseases and healthy controls.

Hai-Hui Huang1, Xiao-Ying Liu1, Yong Liang1, Hua Chai1, Liang-Yong Xia1.   

Abstract

Tuberculosis (TB), caused by infection with mycobacterium tuberculosis, is still a major threat to human health worldwide. Current diagnostic methods encounter some limitations, such as sample collection problem or unsatisfied sensitivity and specificity issue. Moreover, it is hard to identify TB from some of other lung diseases without invasive biopsy. In this paper, the logistic models with three representative regularization approaches including Lasso (the most popular regularization method), and L1/2 (the method that inclines to achieve more sparse solution than Lasso) and Elastic Net (the method that encourages a grouping effect of genes in the results) adopted together to select the common gene signatures in microarray data of peripheral blood cells. As the result, 13 common gene signatures were selected, and sequentially the classifier based on them is constructed by the SVM approach, which can accurately distinguish tuberculosis from other pulmonary diseases and healthy controls. In the test and validation datasets of the blood gene expression profiles, the generated classification model achieved 91.86% sensitivity and 93.48% specificity averagely. Its sensitivity is improved 6%, but only 26% gene signatures used compared to recent research results. These 13 gene signatures selected by our methods can be used as the basis of a blood-based test for the detection of TB from other pulmonary diseases and healthy controls.

Entities:  

Keywords:  Tuberculosis; biomarkers; early diagnostic; feature selection; regularization

Mesh:

Substances:

Year:  2015        PMID: 26405955     DOI: 10.3233/BME-151486

Source DB:  PubMed          Journal:  Biomed Mater Eng        ISSN: 0959-2989            Impact factor:   1.300


  3 in total

1.  Integrating molecular interactions and gene expression to identify biomarkers and network modules of chronic obstructive pulmonary disease.

Authors:  Hai-Hui Huang; Yong Liang
Journal:  Technol Health Care       Date:  2022       Impact factor: 1.205

2.  Blood transcriptional biomarkers for active pulmonary tuberculosis in a high-burden setting: a prospective, observational, diagnostic accuracy study.

Authors:  Carolin T Turner; Rishi K Gupta; Evdokia Tsaliki; Jennifer K Roe; Prasenjit Mondal; Georgina R Nyawo; Zaida Palmer; Robert F Miller; Byron Wp Reeve; Grant Theron; Mahdad Noursadeghi
Journal:  Lancet Respir Med       Date:  2020-03-13       Impact factor: 30.700

3.  Concise whole blood transcriptional signatures for incipient tuberculosis: a systematic review and patient-level pooled meta-analysis.

Authors:  Rishi K Gupta; Carolin T Turner; Cristina Venturini; Hanif Esmail; Molebogeng X Rangaka; Andrew Copas; Marc Lipman; Ibrahim Abubakar; Mahdad Noursadeghi
Journal:  Lancet Respir Med       Date:  2020-01-17       Impact factor: 30.700

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.